Table 3.
Sex | Age | Professional experience | ||||
---|---|---|---|---|---|---|
ρ† | P | ρ† | P | ρ† | P | |
Medical education program for the ‘Treatment Guideline for Pharmacological Therapy for Schizophrenia’ | ||||||
Total clinical knowledge score at baseline | −0.09 | 0.11 | 0.02 | 0.74 | 0.07 | 0.17 |
Total clinical knowledge score after the program | −0.04 | 0.48 | −0.06 | 0.29 | 0.01 | 0.83 |
Medical education program for ‘Treatment Guideline II: Major Depressive Disorder’ | ||||||
Total clinical knowledge score at baseline | −0.09 | 0.11 | 0.10 | 0.05 | 0.28 | 1.8 × 10 −7 |
Total clinical knowledge score after the program | −0.05 | 0.38 | 0.05 | 0.39 | 0.18 | 7.7 × 10 −4 |
Spearman's rank correlation coefficient.
The significance level was set at two‐tailed P < 6.3 × 10−3 as the Bonferroni method was applied.
A correlation coefficient (ρ) of 0.2 to 0.4 indicates a weak correlation.
Significant P‐values are boldfaced.